Early events in islets and pancreatic lymph nodes in autoimmune diabetes

Journal of Autoimmunity

Volumn 23, Issue 1, 2004, Pages 27-35

  Aspord, Caroline ^a   Rome, Sophie ^a   Thivolet, Charles ^a  

^a INSERM   (France)

Author keywords

autoimmunity; cDNA array; diabetes; islets; NOD; NOD mice; nonobese diabetic; pancreatic lymph nodes; PLN

Indexed keywords

CD3 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 11; OSTEOPONTIN;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; DNA MICROARRAY; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; IMMUNOPATHOLOGY; IMMUNOREGULATION; INTERLEUKIN 1 GENE; LYMPH NODE; LYMPHOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOPONTIN GENE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES COMPARISON; T LYMPHOCYTE; TIME; TYNFSF13B GENE;

AGE FACTORS; ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION PROFILING; ISLETS OF LANGERHANS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 3242731966     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2004.03.007     Document Type: Article

References (29)

1. Notkins A.L., Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest. 108:2001;1247-1252
2. Mandrup-Poulsen T. Beta-cell apoptosis: stimuli and signaling. Diabetes. 50:(Suppl. 1):2001;S58-S63
3. Mauricio D., Mandrup-Poulsen T. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes. 47:1998;1537-1543
4. Trudeau J.D., Dutz J.P., Arany E., Hill D.J., Fieldus W.E., Finegood D.T. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes. 49:2000;1-7
5. Mathis D., Vence L., Benoist C. Beta-cell death during progression to diabetes. Nature. 414:2001;792-798
6. Gershon D. Microarray technology: an array of opportunities. Nature. 416:2002;885-891
7. Cardozo A.K., Kruhoffer M., Leeman, Orntoft R., Eizirik D.L. Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes. 50:2001;909-920
8. Song F., Srinivasan M., Aalinkeel R., Patel M.S. Use of a cDNA array for the identification of genes induced in islets of suckling rats by a high-carbohydrate nutritional intervention. Diabetes. 50:2001;2053-2060
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159
10. Ploix C., Bergerot I., Fabien N., Perche S., Moulin V., Thivolet C. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes. Diabetes. 47:1998;39-44
11. Santamaria P. Effector lymphocytes in autoimmunity. Curr Opin Immunol. 13:2001;663-669
12. Charre S., Rosmalen J.G., Pelegri C., Alves V., Leenen P.J., Drexhage H.A., et al. Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period. Histol Histopathol. 17:2002;393-401
13. Mackay F., Mackay C.R. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 23:2002;113-115
14. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 190:1999;1697-1710
15. Rennert P.D., Browning J.L., Mebius R., Mackay F., Hochman P.S. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med. 184:1996;1999-2006
16. Ettinger R., Munson S.H., Chao C.C., Vadeboncoeur M., Toma J., McDevitt H.O. A critical role for lymphotoxin-beta receptor in the development of diabetes in nonobese diabetic mice. J Exp Med. 193:2001;1333-1340
17. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 287:2000;860-864
18. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:2001;1731-1735
19. Bozza M., Bliss J.L., Dorner A.J., Trepicchio W.L. Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J Interferon Cytokine Res. 21:2001;21-30
20. Trepicchio W.L., Wang L., Bozza M., Dorner A.J. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol. 159:1997;5661-5670
21. Nicoletti F., Zaccone P., Conget I., Gomis R., Moller C., Meroni P.L., et al. Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD mice. Diabetes. 48:1999;2333-2339
22. Fabien N., Bergerot I., Maguer-Satta V., Orgiazzi J., Thivolet C. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice. J Autoimmun. 8:1995;323-334
23. Yamada K., Nonaka K., Hanafusa T., Miyazaki A., Toyoshima H., Tarui S. Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice. Diabetes. 31:1982;749-753
24. Gonzalez C., Menissier De Murcia J., Janiak P., Bidouard J.P., Beauvais C., Karray S., et al. Unexpected sensitivity of nonobese diabetic mice with a disrupted poly(ADP-Ribose) polymerase-1 gene to streptozotocin-induced and spontaneous diabetes. Diabetes. 51:2002;1470-1476
25. Heimberg H., Heremans Y., Jobin C., Leemans R., Cardozo A.K., Darville M., et al. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes. 50:2001;2219-2224
26. Jensen P.L. Eph receptors and ephrins. Stem Cells. 18:2000;63-64
27. Adams R.H., Klein R. Eph receptors and ephrin ligands, essential mediators of vascular development. Trends Cardiovasc Med. 10:2000;183-188
28. Cheng N., Chen J. Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism. J Biol Chem. 276:2001;13771-13777
29. Gu C., Park S. The EphA8 receptor regulates integrin activity through p110 gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol Cell Biol. 21:2001;4579-4597